Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer.
about
Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implicationsPrevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agentsMelatonin and Fertoprotective Adjuvants: Prevention against Premature Ovarian Failure during Chemotherapy.Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservationOvarian stimulation in patients with breast cancerIs transplantation of a few leukemic cells inside an artificial ovary able to induce leukemia in an experimental model?Developmental Status: Impact of Short-Term Ischemia on Follicular Survival of Whole Ovarian Transplantation in a Rabbit Model.Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based NomogramAge, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamideFertility Preservation for the Young Breast Cancer PatientPilot initiative in India to explore the gonadal function and fertility outcomes of a cohort of childhood cancer survivorsPreserving Fertility in Children and Adolescents with Cancer.Fertility preservation in women.Chemotherapy-induced damage to ovary: mechanisms and clinical impact.The past, present and future of fertility preservation in cancer patients.Successful controlled ovarian stimulation and vitrification of oocytes in an adolescent diagnosed with myelodysplastic/pre-malignant clone with monosomy 7.Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases.Histological evaluation of the effect of VEGF on auto-transplanted mouse ovaries
P2860
Q28239980-8174859C-A344-43CA-AD5F-9137E5007EBFQ28240178-DFC4B137-21EF-4856-962E-0AFE15904088Q33838766-51247C80-FF13-41C6-AF70-664FC7F4FBB2Q34127500-AA23C28B-4710-4FC6-A10C-2D8B3CDE1770Q35106191-64FA6C57-81BE-4D53-B341-A76D636905A9Q35236668-884C4FA1-D366-48F5-8D66-B16B44B4FFCEQ35745239-37F801F9-6D92-407B-AC41-E0B1677D3257Q35815806-50E7F315-72AF-421E-9B69-96A4A712FF2AQ36116355-E5DADE75-1990-408A-8011-6FF6C2C5FFDBQ36370462-5E5AB065-6D64-406B-BC0A-426632096678Q36936518-12D623E1-BAE8-4E5A-AEF8-0DF99E8A817EQ37024928-DB000340-DDDB-4C3F-A11E-1F43F7D01536Q37055811-6EA1E675-D0C4-40CF-93D6-8CE9E90A4BB9Q38156039-D28DF161-D97F-4B12-A338-39A6AA4CBEADQ38842887-1A83E863-FB43-439A-956B-093698D97F13Q38965305-1FA98A2F-2E60-49B3-B830-D0C3788580AAQ39418670-672E76C8-5FF6-4A19-828D-9FD38B1B19F4Q51152231-7A11431B-71EC-4A65-88DF-65E630611156Q57430305-93F70514-1F7E-4C12-B00B-FFAAD332F10E
P2860
Antimüllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antimüllerian hormone, the ass ...... the young patient with cancer.
@en
type
label
Antimüllerian hormone, the ass ...... the young patient with cancer.
@en
prefLabel
Antimüllerian hormone, the ass ...... the young patient with cancer.
@en
P1476
Antimüllerian hormone, the ass ...... the young patient with cancer.
@en
P2093
Richard A Anderson
P304
P356
10.1016/J.FERTNSTERT.2013.03.014
P407
P577
2013-03-27T00:00:00Z